Shore Capital Partners has merged Reliant Healthcare and Care Fusion Rx to establish a nationwide infusion therapy platform aimed at expanding access to home and ambulatory infusion services nationwide. The combined company is positioned to deliver comprehensive, patient-centered care with a strong focus on clinical excellence.
Chicago-based Shore, which also operates an office in Nashville, announced that the merger brings together two organizations with deep expertise across complex infusion treatments. Reliant Healthcare, founded in 2008, operates 14 ambulatory infusion centers and multiple specialty pharmacies across Louisiana, Texas, and Oklahoma, serving patients across therapeutic areas including neurology, immunology, oncology, rare disease, rheumatology, and gastroenterology. Care Fusion Rx, established in 2020 and based in California, specializes in advanced immunoglobulin and biologic therapies and serves patients across the West Coast.
The new platform aims to expand access to infusion therapy at home and in clinical centers by leveraging the complementary geographic presence and clinical capabilities of both organizations. Leadership from both companies emphasized that the merger will enhance the consistency, quality, and affordability of infusion services for thousands of patients with chronic and rare diseases.
The unified company will be led by a seasoned team of healthcare operators supported by Shore Capital’s Healthcare Advantage Fund, which is focused on building market-leading healthcare platforms. This represents the third investment from the Advantage Fund, which targets both external acquisitions and existing microcap companies within Shore’s portfolio.
The combined enterprise is expected to accelerate growth through new infusion center openings, expanded home infusion service areas, and strategic acquisitions in high-growth and underserved markets. Industry veteran Frank Alderman, M.D., Co-Founder and former CEO of MedExpress, will serve as Lead Independent Director, bringing additional experience in scaling national healthcare service platforms.
Shore Capital and the two merging companies were advised by a group of financial and legal partners, including Houlihan Lokey, Guggenheim Securities, DLA Piper, McDermott Will & Emery, Quarles & Brady, Brentwood Capital, Bass Berry & Sims, Covington Associates, and Polsinelli.
KEY QUOTES
“We are thrilled to partner with Reliant and Care Fusion to build a differentiated infusion platform focused on quality, access, and growth.”
Mike Cooper, Partner, Shore Capital
“This partnership represents a tremendous opportunity to enhance how and where patients receive infusion therapy. By combining two organizations with deep clinical expertise and shared values, we are creating a platform capable of delivering even more consistent, accessible, affordable, and compassionate care to patients who rely on these therapies every day.”
Brad Smith, CEO, Reliant Healthcare
“At Care Fusion, our focus has always been on providing patients with the highest level of care and service.”
Wayne Nash, Co-Founder, Care Fusion Rx
“Joining forces with Reliant allows us to extend that commitment to more patients, leverage our combined operational strengths, and continue improving outcomes for individuals living with chronic and rare conditions.”
Steve Roberts, Co-Founder, Care Fusion Rx
“We are thrilled to partner with Reliant and Care Fusion to build a differentiated infusion platform focused on quality, access, and growth.”
Mike Cooper, Founding Partner, Shore Capital Partners
“This combination brings together exceptional teams who share a passion for patient care and clinical excellence.”
AJ Gauthier, Principal, Shore Capital Partners
“We are building a best-in-class, omnichannel platform focused on providing access to high-quality, patient-centric care while optimizing the site of service. Our compelling value proposition spans the spectrum of patients, providers, payors, health systems, and pharma organizations.”
Frank Alderman, M.D., Lead Independent Director; Co-Founder and Former CEO, MedExpress
